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The diagnosis of odontogenic tumors is often quite complicated due to the heterogeneity of the lesions, borderline forms, and hybrid
forms. Usually, also the classiﬁcation is somewhat controversial. Odontogenic tumors (OTs) include a group of heterogeneous diseases
that range from hamartomatous or non-neoplastic tissue proliferations, to benign neoplasm, and to malignancy [1]. These lesions derive
from epithelial, ecto-mesenchymal, and mesenchymal elements of the tooth forming apparatus. OTs are classiﬁed into 2 large groups:
malignant OTs (MOT) and benign OTs (BOT) [1]. MOT are classiﬁed as carcinomas or sarcomas [2]. Odontogenic carcinomas include
metastatic ameloblastoma (MA), primary or secondary ameloblastic carcinoma (AC), primary intra-osseous squamous cell carcinoma
(PISCC), either arising de novo or from malignant transformation of a keratocystic odontogenic tumor (KOT), or other odontogenic
cysts; clear cell odontogenic carcinoma (CCOC), and ghost cell odontogenic carcinoma (GCOC) [2].
Benign odontogenic tumors are divided in epithelial tumors, mixed tumors, and ecto-mesenchymal tumors [3]. To our knowledge,
only few cases of combined or hybrid odontogenic tumors have been reported in literature [4–6]. The purpose of our study is to describe
a case of a patient with an intraosseus lesion composed by two different components: a benign one, represented by an odontogenic
squamous cell tumor, and a malignant, represented by a clear cells squamous cell carcinoma.
Case report
A 66-year-old male heavy smoker, was referred to Maxillofacial Surgery Department of the University of Naples “Federico II” in June
2016. The patient was suffering from severe obstructive pulmonary disease, HCV-related hepatopathy, and chronic hypertrophic car-
diomyopathy. He presented swelling and pain on the left mandibular area, with a history of gradual increase in symptomatology during
last 7 months. Family background was negative for this kind of lesion. Extra oral examination showed a 30 25 mm hard and painful
mass involving the entire left mandible body, ulcerated in submandibular area. Clinical examination of the neck was negative. Intraoral
exam revealed a poor oral hygiene with widespread periodontal disease and multiple residual roots. A bleeding and painful mucosal
ulceration extended from left mandibular premolar region to ipsilateral tuber maxillae. Paresthesia and weakness of the lower lip were
not reported. Clinically the lesion looked like a squamous cell carcinoma of the alveolar ridge (Fig. 1). An incisional biopsy was per-
formed, resulting in a moderately differentiated squamous cell carcinoma (G2). Total body CT scan was then executed, revealing an
expansive heteroplastic mass of the left mandibular body, measuring about 30 25 mm, and causing erosion both of the vestibular, andAvailable online 3 August 2018
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Basing on these exams, a left mandibulectomy extended to the ipsilateral tuber maxillae in association with a type III left radical
modiﬁed neck dissection, was performed [7]. Due to the high operative risk, bone continuity was not restored and reconstruction was
performed with a myocutaneous pectoralis major ﬂap (Fig. 2). No complications were detected during the post-operative course and the
patient was discharged from the hospital after 11 days. There was no evidence of recurrence at a 6-months follow-up.
Microscopic and immunohistochemical features
Microscopic evaluation of the surgical specimen showed an inﬁltrative tumor with prevailing invaginated growth pattern. The lesion
consisted of some islands of well-differentiated squamous epithelium, irregular in size and shape, and amidst a dense ﬁbrous connective
tissue, numerous nests with central cystic degeneration containing keratin lamellae and coarse calciﬁcations. The lining epithelium of
the nests was both squamous which, partially, constituted by stellate cells. Immunohistochemical evaluation with cytokeratin 19
showed only a partial intralesional positivity while calretinin was negative (Fig. 3). Multifocal neoplastic inﬁltration was observed in the
mandibular bone, instead all the lymph nodes and the salivary gland from lymphadenectomy were negative for tumor.
Histological interpretation was very difﬁcult. Microscopic ﬁndings, while do not exclude the diagnosis of a well differentiated
squamous cell carcinoma, on the other hand suggests, in the ﬁrst instance, the hypothesis of an odontogenic neoplasia, including entities
of both squamous odontogenic tumor and clear cell odontogenic carcinoma (Fig. 4).
Discussion
The surgical assessment of odontogenic tumors is still controversial and represents a great challenge for head and neck surgeons
[24–26]. Clinical examination could guide the surgeon to choose an appropriate therapy protocol. Biopsy is the ﬁrst tool to discover and
clarify the nature of the lesion.
A persistent dilemma for pathologists and clinicians is to determinate the malignancy of the lesions. Traditionally, this evaluation is
based on histopathological aspects such as size and nuclear irregularity, loss of polarity, mitotic index and neoplastic invasion. However,
more practical and reliable methods are required.
Our sample showed a lesion type framed among odontogenic tumors. It combines histological features of an odontogenic neoplasia,
including entities such as the squamous odontogenic tumor and clear cell odontogenic carcinomamimicking a squamous cell carcinoma.
Squamous odontogenic tumor (SOT) is a benign, locally inﬁltrative lesion, that localize to the periodontium. Less than 50 cases have
been reported since the ﬁrst description of SOTs in 1975 [8]. Although the clear etiology of SOTs is unknown, these tumors are
considered arising from the epithelial cell rests of Malassez. Clinically, SOT can be presented as an asymptomatic, slow growing,
intraosseous lesion with few clinical signs and symptoms. Nevertheless, mobility and displacement of teeth, swelling of alveolar process,
and mild to moderate pain are the main ﬁndings. Mandible is affected more often than maxilla, with a preferential occurrence in the
posterior premolar and molar area [8].
SOTs is formed by well-differentiated squamous epithelial cells of different sizes and shapes, surrounded by mature connective tissue
[9]. As result, this lesion is often described as a benign epithelial odontogenic tumor, acanthomatous ameloblastoma, acanthomatous
ameloblastic ﬁbroma or occasionally, well-differentiated squamosus cell carcinoma or pseudoepiteliomatous hyperplasia [10]. A his-
topathological misunderstanding may therefore lead to either therapeutic over- or under-treatment. The prognosis of SOT treatment is
good. Recurrence appears to be rare, and may occur due to incomplete tumor removal [10].
Clear cell odontogenic carcinoma (CCOC) is a rare odontogenic tumor with female predilection occurring in the anterior part of the
mandible with an incidence between 5th and 7th decade of life [11]. Clear cell odontogenic carcinoma was ﬁrst described by Hansen
et al., in 1985 as clear cell odontogenic tumor [12]. World Health Organization (WHO) in 2005 classiﬁed it as a malignant odontogenic
tumor [13,14]. Clinical presentation of CCOC is a painless swelling in the mandible or maxilla [15]. Pain and loose teeth were the
occasionally associated symptoms. Radiologically, the tumors were presented as ill-deﬁned radiolucent lesions [16]. CCOC shows 3
different histological patterns: biphasic, monophasic, and ameloblastomatous [17]. Tumors with clear cell pattern in the head and neck
region can impose serious problems with differential diagnosis. They may originate from different lesions including odontogenic tumors
such as ameloblastoma, calcifying epithelial odontogenic tumor (CEOT), odontogenic carcinoma and salivary glands tumor, intra-
osseous melanocytic tumors, metastatic tumors from kidney, thyroid, prostate, andmelanotic tumor [18,19]. This kind of lesions may be
very well differentiated and involve alveolar bone, displaying microscopic evidence of malignancy. Similarly, bland islands of squamous181
Fig. 1. Preoperative view.
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Fig. 2. Intraoperative view.
Fig. 3. Histopathological features.
Fig. 4. (a) Pre-operative OPT; (b) post-operative OPT.epithelium are not features of primary intraosseous/odontogenic carcinomas [20]. Like in the case we describe, in literature [21,23,27]
a wide surgical resection with tumor-free margins, loco-regional control by lymph node resection and adjuvant radiation in cases with
extensive soft tissue invasion is mandatory. Long-term follow-up is necessary to look for loco-regional recurrence and distant metastasis
to lungs and bone even after appropriate therapy.
Conclusion
The odontogenic tumors are a group of extremely varied disorders that can represent a continuous spectrum of disease or several
different all together. The ﬁnal diagnosis can be made by histopathological evaluation; therefore, the treatment must be surgery, that
appears to be curative for this kind of lesions. The aim of our study is to report our experience about a supposed new pathologic entity, as182
Giovanni Dell’Aversana Orabona et al. Oral and Maxillofacial Surgery Cases 4 (2018) 180–183well as having the characteristics of a hybrid odontogenic tumor mimicking the macroscopic and histologic characteristics of squamous
cell carcinoma, creating further problems for the classiﬁcation and the diagnostic and therapeutic approach. Our framework could be
suggestive for a co-existence of two different odontogenic entities of which the malignant form is degenerated into squamous cell
carcinoma. On the other hand, our sample may be suggestive also of a co-existence, from the beginning, of three different entities
independently. In Sindhu and Namrata’s and Ortiz et al.’s works [21,22], this kind of lesion reveals different microscopic patterns along
with unusual association of squamous cell carcinoma, possibly suggestive of hybrid tumor. To assess this kind of lesions it is, after
surgical resection, safe and important to advise diagnostic aids for the prediction of recurrence, so that radiotherapy can be given after
surgery to avoid recurrence.
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